|
MYST4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76947345664757E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.07243161204951E-13 |
| Normal-vs-Stage2 |
2.15629999966716E-07 |
| Normal-vs-Stage3 |
2.04619999999434E-06 |
| Normal-vs-Stage4 |
3.10100000000535E-06 |
| Stage1-vs-Stage2 |
5.055200E-01 |
| Stage1-vs-Stage3 |
8.468600E-01 |
| Stage1-vs-Stage4 |
8.487400E-01 |
| Stage2-vs-Stage3 |
7.608600E-01 |
| Stage2-vs-Stage4 |
5.245200E-01 |
| Stage3-vs-Stage4 |
7.603000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.50621786949068E-13 |
| Normal-vs-AfricanAmerican |
4.37339997549913E-09 |
| Normal-vs-Asian |
1.031040E-04 |
| Caucasian-vs-AfricanAmerican |
5.885200E-01 |
| Caucasian-vs-Asian |
9.619200E-01 |
| AfricanAmerican-vs-Asian |
8.015800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05391259555654E-14 |
| Normal-vs-Female |
7.561700E-04 |
| Male-vs-Female |
3.985400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.79550000037432E-07 |
| Normal-vs-Extreme_Weight |
1.68132174849234E-12 |
| Normal-vs-Obese |
2.22630003321456E-09 |
| Normal-vs-Extreme_Obese |
5.1957000035685E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.543560E-01 |
| Normal_Weight-vs-Obese |
8.121000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.756000E-01 |
| Extreme_Weight-vs-Obese |
4.956200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.543000E-01 |
| Obese-vs-Extreme_Obese |
2.824200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.32239999997663E-06 |
| Normal-vs-Age(41-60Yrs) |
3.6109000234319E-09 |
| Normal-vs-Age(61-80Yrs) |
1.67355018731996E-12 |
| Normal-vs-Age(81-100Yrs) |
4.667100039768E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.729000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.664800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.866450E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.850300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.503400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.722800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.70463643200947E-12 |
| Normal-VS-Type2 PRCC |
4.9382720135327E-12 |
| Normal-VS-KIRP CIMP |
2.44819999999368E-05 |
| Normal-VS-Unclassified PRCC |
3.996200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.590800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.690200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.429700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.570200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.730100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.707600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.17794662912729E-13 |
| Normal-vs-N1 |
7.585200E-04 |
| Normal-vs-N2 |
2.570000E-04 |
| N0-vs-N1 |
5.188400E-02 |
| N0-vs-N2 |
8.774200E-01 |
| N1-vs-N2 |
4.456000E-01 |
|
|
